Coming Soon!
Close
Close

Pharmacy Benefit News

   Designed specifically to educate and update readers on key issues and concerns.

Search ALL Pharmacy Benefit News

2019

Issue # 360 | October 31, 2019

  • Commentary: RETAIL HEALTHCARE IS DRIVING MORE THAN LOWER COSTS
  • Commentary: IF UNIVERSAL HEALTHCARE IS SO EXPENSIVE, THEN WHY IS IT THAT SO MANY OTHER COUNTRIES CAN AFFORD IT?
  • Commentary: RETAIL PHARMACY EXPERIMENTS WITH DIALYSIS

 

Issue # 359 | October 17, 2019

  • Commentary: HOW SMALL BUSINESSES COPE WITH THE RISING COST OF HEALTH CARE -- HSAs
  • Commentary: HOW SMALL BUSINESSES COPE WITH THE RISING COST OF HEALTH CARE – SELF-INSURANCE and ASSOCIATION HEALTH PLANS
  • Commentary: HOW SMALL BUSINESSES COPE WITH THE RISING COST OF HEALTH CARE – OPTIONS TO LOWERING THE COST

 

Issue # 358 | October 3, 2019

  • Commentary: PREVENTION IS THE ANSWER, BUT IT IS SO HARD TO DO!
  • Commentary: CELEBRITY DEATHS EMPHASIZE MORE THAN UNHAPPINESS
  • Commentary: HEALTH CARE PROGRAMS ARE EXPERIMENTS

 

Issue # 357 | September 19, 2019

  • Commentary: Call to Action – Immunizations For 16 Year Old’s
  • Commentary: Anti-Vaxers – Here Is the Data!
  • Commentary: Science Tries to Catch Up with Vaping!

 

Issue # 356 | August 22, 2019

  • Commentary: Pharmacies Take the Initiative to Lower Cost and Extend Services
  • Commentary: How to Finance Health Care for All?
  • Commentary: How Can Patients and Plans Take Advantage of Drugs Cost Below Current Contract Prices?

 

Issue # 355 | August 18, 2019

  • Commentary: Medicare for All (M4A) - The Math Argument
  • Commentary: How Do Countries Achieve Universal Healthcare?
  • Commentary: Uncertainty and Transparency Drive Health Care

 

Issue # 354 | July 25, 2019

  • Commentary: SPECIAL ISSUE – COMMON BELIEFS– TRUE OR FALSE?
  • Commentary: COMMON BELIEFS – TRUE OR FALSE? (Part 2)
  • Commentary: COMMON BELIEFS – TRUE OR FALSE? (Part 3)

 

Issue # 353 | July 11, 2019

  • Commentary: SPECIAL ISSUE – COMMON REMEDIES – TRUE OR FALSE?
  • Commentary: COMMON REMEDIES – TRUE OR FALSE? (Part 2)
  • Commentary: COMMON REMEDIES – TRUE OR FALSE? (Part 3)

 

Issue # 352 | June 13, 2019

  • Commentary: Where Can We Expect Healthcare Innovations In 2019?
  • Commentary: How to Finance Health Care for All? – Ask the Chinese!
  • Commentary: Artificial Intelligence (Ai) Vs. Humans – Who Wins?

 

Issue # 351 | May 30, 2019

  • Commentary: Disaster Spells Non-Compliance
  • Commentary: Hospitals and Insurers Resist Price Transparency
  • Commentary: Dental Care Goes Retail!

 

Issue # 350 | May 16, 2019

  • Commentary: Blame - From Current News
  • Commentary: Opiate Overdose Issues
  • Commentary: Opiate Overdose Responses

 

Issue # 349 | May 2, 2019

  • Commentary: Anti-Vaxers – Here Is the Data!
  • Commentary: Prescription Coupons – The Bane of Health Plans
  • Commentary: Health Care Stakeholders Use Words and Concepts That Providers and Patients Don’t Understand

 

Issue # 348 | April 18, 2019

  • Commentary: Where Can We Expect Healthcare Innovations In 2019?
  • Commentary: Prices Are Higher in The Us!
  • Commentary: Who Drives Up Drug Prices?

 

Issue # 347 | April 4, 2019

  • Commentary: Control Drug Prices - The Industry Says No!
  • Commentary: Copays Versus Cost - Who Pays?
  • Commentary: Certificate of Need (CON) Versus Price Transparency

 

Issue # 346 | March 21, 2019

  • Commentary: Wall Street Pursues Employee-Benefit Programs
  • Commentary: Generic Insulins – Where Are They?
  • Commentary: The Patent Cliff In 2019

 

Issue # 345 | March 7, 2019

  • Commentary: What Is the Transparency Goal?
  • Commentary: Internationalism Brings Its’ Own Rewards?
  • Commentary: Measles Kills. Vaccines Do Not.

 

Issue # 344 | February 21, 2019

  • Commentary: If Medicare Is Running Out of Money, Then Are Benefit Reductions Next?
  • Commentary: US Workers Take Bigger Out-Of-Pocket Costs Due to Health Care Deductibles
  • Commentary: Access, Coverage, & Affordability. What the Patient Wants!

 

Issue # 343 | February 7, 2019

  • Commentary: Medicare for All (M4A) - The Math Argument
  • Commentary: How Do Countries Achieve Universal Healthcare?
  • Commentary: Uncertainty and Transparency Drive Health Care

 

Issue # 342 | January 24, 2019

  • Commentary: Unfounded Myths about Migration and Health Have Become Accepted, and are Used to Justify Policies of Exclusion
  • Commentary: Pharmacies Take the Initiative to Lower Costs And Extend Services
  • Commentary: Don’t Stop Statins for Cholesterol Regardless of The Risks!

 

Issue # 341 | January 10, 2019

  • Commentary: The US, China and India Have Largest Number of Counterfeit & Fake Meds
  • Commentary: God and Professionalism
  • Commentary: "Telehealth" Takes Center Stage

 

2018

Issue # 340 | December 13, 2018

  • Commentary: Do Plans, Employers and Patients Pay for Drugs at the Most Current Prices?
  • Commentary: Do PBMs Confirm that the Correct Basis of Cost is used to Price Claims?
  • Commentary: How Can Patients and Plans Take Advantage of Drug Costs Below Current Contract Prices?

 

Issue # 339 | November 27, 2018

  • Commentary: Are Employers and Plans Paying for Only Their Own Members?
  • Commentary: Are Plans and Employers Paying for Generics When They Are Available?
  • Commentary: Are Plans and Employers Paying for Refills When the Prescriber Is No Longer Available or a Covered Network Physician?

 

Issue # 338 | November 1st, 2018

  • Commentary: If Doctors Know the Cost, Will They Prescribe Cheaper Drugs?
  • Commentary: Patients Could Save Big if They Shop Around!
  • Commentary: Japanese and European Live Longer than Americans. It's Time to Move!

 

Issue # 337 | October 18th, 2018

  • Commentary: Free Markets Will Save Healthcare. So, Why Are We Still Not Doing It?
  • Commentary: If Medicare Is Running Out of Money, Then Are Benefit Reductions Next?
  • Commentary: Big Data Analytics Is the Solution If It Were Not for The Privacy Problems

 

Issue # 336 | October 4, 2018

  • Commentary: One Dose for Aspirin for Primary Prevention Is Not the Optimum!
  • Commentary: Now Companies Are Moving to Reduce the Prices of Drugs For Their Employees
  • Commentary: Specialty Trend Up 9.4% While Traditional Drug Trend Down 4%

 

Issue # 335 | September 20, 2018

  • Commentary: Ia Amazon the Disruptor?
  • Commentary: Medicare for All (M4A) – The Math Argument
  • Commentary: Drug Pricing Controls take Center Stage

 

Issue # 334 | September 5, 2018

  • Commentary: Lying In Health Care Leads To Bad Decisions
  • Commentary: Heartburn Medications Alter The Gut
  • Commentary: Drug Ads as Education

 

Issue # 333 | August 23, 2018

  • Commentary: Diabetic Treatment Plans Are Not Just About Drugs!
  • Commentary: Healthcare Is Local
  • Commentary: Blockchain Is Coming!

 

Issue # 332 | August 9, 2018

  • Commentary: Some Health Care Predictions for 2018 Were Correct!
  • Commentary: Millennials Yes, But What About Gen Z?
  • Commentary: What Can Policy Makers Do to Reduce Drug Prices?

 

Issue # 331 | July 12, 2018

  • Commentary: US Workers Take Bigger Out-Of-Pocket Costs Due to Health Care Deductibles
  • Commentary: Generic Drug Prices Expected to Decrease 7% - 9% Annually
  • Commentary: Price Competition Comes to Treatments for Hepatitis C

 

Issue # 330 | June 26th, 2018

  • Commentary: If Cost Sharing Increases, And Deductibles Rise, Then How Will People Afford Drugs?
  • Commentary: What Will Be the Sources of Capital In The Future For New Health Care Advances? Where Will Plans Get New Capital? Will It Be Consolidation?
  • Commentary: What Can Be Done Right Now to Address the Shortage of EpiPen?

 

Issue # 329 | June 14th, 2018

  • Commentary: What are the Right Limits on Opioid Prescriptions?
  • Commentary: Learning from the Kubler-Ross Model Can Assist with Acceptance to Change
  • How Do You Evaluate Your Heart Risk?

 

Issue # 328 | May 31st, 2018

  • Commentary: Commentary: What Is the FDA Approval Process?
  • Commentary: Access, Coverage, & Affordability. What the Patient Wants!
  • Commentary: Do Generics Bend the Cost Curve?

 

Issue # 327 | May 17th, 2018

  • Commentary: How Do Countries Achieve Universal Healthcare?
  • Commentary: Firearm Injuries Cost Lives and Money
  • Commentary: Unnecessary Opioids and Unnecessary Prescriptions

 

Issue # 326 | May 3rd, 2018

  • Commentary: Who Do Physicians Work For?
  • Commentary: Geography Matters When It Comes to Paying for Health Care
  • Commentary: What Is an Alternative to Opiates for Acute Pain?

 

Issue # 325 | April 19th, 2018

  • Commentary: Hospital Readmissions – An Improvement in Care or In Insurance?
  • Commentary: Hospital Star Ratings Depend On…
  • Commentary: How Do We Get People to Comply With Exercise, Food And Prevention?
  • Maximum Allowable Cost™

 

Issue # 324 | April 5th, 2018

  • Commentary: Why are plans buying PBNs??
  • Commentary: Do prices rise when hospitals merge?​
  • Commentary: Who makes health care policy?
  • Maximum Allowable Cost™

 

Issue # 323 | March 21, 2018

  • What Are the Major Challenges of Health Care Today?
  • How to Stop Nicotine Addiction – Decrease Nicotine in Cigarettes!​
  • Subcategorizing Health Care Problems Will Not Solve Opiate Overuse
  • JCode Calculator™

 

Issue # 322 | March 8, 2018

  • We Get a Test Result, But What Does it Mean to My Current and Future Health?
  • How Do I Know If I Have A Health Risk If No One Tells Me?
  • National Health Spending Growth of 5.5% Annually – What Are Patients to Do?
  • Forecast & Prediction™

 

Issue # 321 | February 22, 2018

  • Commentary: Wearable Healthcare Technology Is the Next Step
  • Commentary: Wearable Healthcare Technology Is the Next Step
  • Commentary: Older Americans Are Taking Too Many Unneeded Drugs
  • Concurrent Audit and Analyses™

 

Issue # 320 | February 7, 2018

  • Commentary: The Most Popular Prescription Drugs In The U.S.
  • Commentary: What Technology Advancements Receive The Most Interest?
  • Commentary: Inflation In Specialty Drug Prices Is 9%
  • Specialty Medication Analysis™

 

Issue # 319 | January 25, 2018

  • Commentary: More Flu Can Be Prevented​
  • Commentary: How To Budget Rebates?
  • Commentary: Hospital Closures High In States That Rejected Medicaid Expansio
  • Biotech Modeling™

 

Issue # 318 | January 11, 2017

  • Commentary: Health Care Organizations – The Challenge!
  • Commentary: Uncertainty and Transparency Drive Health Care
  • Commentary: The Role of Analytics in Health Care
  • Biotech Modeling™

 

2017

Issue # 317 | December 14, 2017

  • A Ding to Vitamin D Use
  • Does Genotyping Reduce Adverse Effects from Warfarin?
  • Control Drug Prices – The Industry Says No!
  • Forecasting & Predictions™

 

Issue # 316 | November 30, 2017

  • E-Prescribing for Opiates – No One Can Hide!
  • If You Can’t Get a Prescription in One State, Then Try Another
  • How Do You Tell a Biosimilar from The Reference Product?
  • Trend Management & Disease Maps™

 

Issue # 315 | November 2, 2017

  • The Opiate Epidemic Is Everyone’s Problem, and Must Be Fixed By Us All
  • Commentary – Necessities To Counter The Opioid Epidemic​
  • Who Prescribes High Dose Opiates? Not The Emergency Department!​
  • Request for Proposal Managment™

 

Issue # 314 | October 19, 2017

  • Employer Premiums for Health Care – Regional Differences​
  • What Patients Want and What They Get​
  • CVS Pharmacies and CVS Caremark Are Attacking Opiate Abuse​
  • Clinical Compliance™

 

Issue # 313 | October 5, 2017

  • Special Edition ​
  • Patient Specific Queries™

 

Issue # 312 | September 21st, 2017

  • Three Years Later, Where Are We Now with Accountable Care Organizations?
  • Who Is a Diabetic?
  • If Clinical Guidelines Are Not Followed, Then Why Have Them?​
  • Retrospective Audit™

 

Issue # 311 | September 7th, 2017

  • What to Do If an Antidepressant Doesn’t Work?
  • What Does Cholera Have to Do with Opiate s?
  • Coffee Lowering Death Rate – Truth or Myth?​
  • Prior Authorization™

 

Issue # 310 | August 24th, 2017

  • Co-Pays vs. Cost - Who Pays?
  • Commentary: Identifying Patients at Risk for Opiate Abuse
  • Commentary: Antibiotics Are Curative, But When to Stop?​
  • Claims Oversight Managment™

 

Issue # 309 | August 10th, 2017

  • Commentary: Rx Spending Growth In 2016
  • Commentary: Financial Pressures Increasing for Hospitals
  • Commentary: Certificate Of Need (CON) Versus Price Transparency​
  • Market Share Analyses™

 

Issue # 308 | July 27th, 2017

  • Commentary: Is Comparison Shopping in Health Care Easy to Do?
  • Commentary: What Are the Correct Wellness Priorities?
  • Commentary: Is Selling Health Insurance Across State Lines a Promising Idea?
  • Treatment Calendar™

 

Issue # 307 | July 13th, 2017

  • Increase in American Workers Testing Positive for Drugs
  • Opioid Addiction in the Hands Of Legislators
  • Butterflies in Your Stomach? Or Is That Just Called Anxiety
  • Invoice Screens™

 

Issue # 306 | June 29th, 2017

  • Commentary: The Math Must Work
  • Commentary: Specialty Rx Challenges All Treatment Effectiveness, Risk and Affordability
  • Commentary: Value-Based Care Seems to Have Legs
  • Financial, Preformance & Claims Audits™

 

Issue # 305 | June 15th, 2017

  • Healthcare Trends Have No Roadblocks
  • Using Technology for Proactive Health
  • Communication Increases Compliance to Medical Tests
  • JCode Calculator™

 

Issue # 304 | June 1st, 2017

  • ​Majority of Cardiologist Depend on PhRMA for Drug Information
  • Commentary: Poloticians Need to Know
  • What Were the Top Five Prescription Medications by Revenue in 2016?
  • Fraud Waste & Abuse™

 

Issue # 303 | May 18th, 2017

  • ​How Does the Medical Community Decide What is High Blood Pressure?
  • Commentary: Is 5 times higher really 5x higher?
  • Commentary: How Do We Predict the Progression of Diabetes Severity Over Time?
  • Maximum Allowble Cost™

 

Issue # 302 | May 4th, 2017

  • US Health Care Spend
  • Declining Drug Prices
  • Corporate Alliance to Lower Health Care Spend
  • Quality Managment Program™

 

Issue # 301 | April 20th, 2017

  • The Trump Administration & Opiates
  • Incidence of Dementia Declined Over Three Decades in The Framingham Heart Study
  • Analytics Works to Identify Undiagnosed Patients
  • Comprehensive Specialty Analysis™

 

Issue # 300 | April 6th, 2017

  • The American Health Care Act & Medical Trusts - A Commentary
  • Retail Pharmacies Enter the Specialty Market
  • A New Drug Treatment for Parkinson's Disease - A Commentary
  • Comprehensive Medication Review™

 

Issue # 299 | March 23rd, 2017

  • How Patient Desires Drive Marketing Realities for the Future
  • Patient Desires Drive Retail Business Changes
  • Drug Spending - A Commentary
  • Biotech Modeling™

 

Issue # 298 | March 9th, 2017

  • How Do You Identify a Potential Adverse Drug Reaction?
  • Two Chronic Health Conditions Drive 25% of Treatments
  • Off Label Uses of Drugs is a Big Problem
  • Request for Proposal Managment™

 

Issue # 297 | February 23rd, 2017

  • “Remnant Cholesterol” is Associated with Increased Cardiovascular Events
  • Studies Link Presenteeism to Job Demands
  • 3 Drug Classes That Can Cause Raynaud's Disease
  • Request for Proposal Managment™

 

Issue # 296 | February 9th, 2017

  • Specialty Pharmaceuticals:The New Frontier
  • The Value of Subsidies And Cost-Sharing For Prescription Drugs
  • What Was the Progress of Healthcare in 2016?
  • Comprehensive Specialty Analyses™

 

Issue # 295 | January 26th, 2017

  • 3 Drug Classes That Can Cause Raynaud's Disease
  • Studies Link Presenteeism to Job Demands
  • "Remnant Cholesterol" is Associated with Increased Cardiovascular Events in Diabetics
  • Comprehensive Specialty Analyses™

 

Issue # 294 | January 12th, 2017

  • HHS Takes Next Step in Advancing Health Equity Through ACA
  • Kmart Suing Catamaran (a PBM) For Underpaying Pharmacies Payments for Prescription Drugs
  • Commentary: Some Clinical Pearls
  • RFP Review™

 

2016

Issue # 293 | December 15th, 2016

  • Characteristics Associated With Hospital Readmissions
  • CVS Touts the Benefits of Tobacco Bans
  • Medicare Recipients Dive Faster Into the 'Donut Hole'
  • ProData Analytics™

 

Issue # 292 | November 30th, 2016

  • 340b - Who is Eligible? Who Can Prescribe?
  • Oxycodone for Kids?
  • Heart Attacks and Stroke May be Dependent on Cardiac Age, Not Chronological Age
  • JCode Calculator™

 

Issue # 291 | November 3rd, 2016

  • Commentary: Diagnostic Errors in Primary Care -- An Underappreciated Problem
  • Commentary: Medi-Cal and Medicaid - A Shared Accountability Program
  • Commentary: Drug Pricing Analyses Add to the Growing Controversery
  • Fraud, Waste and Abuse™

 

Issue # 290 | October 20th, 2016

  • Commentary: Insurance Cooperatives Launched With ACA Funding
  • Commentary: Some Problems with Interpreting Big Data
  • Immunization Registries Attempt to Coordinate Information From Different Sources
  • Fraud, Waste and Abuse™

 

Issue # 289 | October 6th, 2016

  • Commentary: Financing Policy vs. Healthcare Policy
  • Prediction
  • Aetna Contacting Physicians Who May Be Over-Prescribing Opioids
  • Maximum Allowable Cost (MAC)™

 

Issue # 288 | September 22nd, 2016

  • FDA Panel Says No to Abuse Deterrent Opiate/li>
  • Insurers’ Mergers Exposes Healthcare Industry Divide
  • PBMs Lose Iowa Lawsuit Against Drug Pricing Transparency
  • JCode Calculator™

 

Issue # 287 | September 8th, 2016

  • Demand for Generics Fuels Growth in Market Share
  • 2016 Pharmacy Trends
  • Commentary: Increases In Medical Cost Are Driven By More Than Price
  • Comprehensive Specialty Analyses™

 

Issue # 286 | August 11th, 2016

  • If Patients Don't Comply With Their ADHD Meds, Then Does This Mean There Is An Increased Risk for Illicit Drug Use?
  • PhRMA Tries Again to Get Patients to Comply
  • Pharmacists Prescribe Birth Control Pills in Missouri?
  • Custom Maximum Allowable Cost (MAC) List™

 

Issue # 285 | August 11th, 2016

  • How To Reduce Inappropriate Antibiotic Prescriptions? Try Behavior Modification
  • FDA Rejects Expanded Use of Ivacaftor in Patients With Specific Mutations!
  • The FDA Takes a New Approach to Opiates
  • Trend Management™

 

Issue # 284 | July 26th, 2016

  • Xerostomia: Not as Dry a Topic as You’d Think
  • Prostate Cancer: Actively Forgoing Treatment
  • ADHD: A Disorder of the Brain or the Diagnosis?
  • Operational Strategy and Strategic Implementation™

 

Issue # 283 | June 14th, 2016

  • Does a Family History of Mental Illness Impact Their Children?
  • Does the FDA Have a Role in the Affordability of Generic Pharmaceuticals?
  • Prescription Drug Prices Increased 9.4% in 2013
  • Data Analytics™

 

Issue # 282 | June 30th, 2016

  • Opioid Dangers – Do Doctors and Patients Care?
  • Opiate Addiction – Are Pharmacists the Last Line of Defense?
  • Commentary Piece
  • Allergan & Perrigo Launch Store-Brand Expectorant and Nasal Decongestant™

 

Issue # 281 | June 16th, 2016

  • How To Afford High Priced Drugs
  • Long Tern Statin Use Leads to Kidney Disease
  • Commentary Piece
  • Fraud, Waste and Abuse™

 

Issue # 280 | June 2nd, 2016

  • Drug Discontinuation Is Dependent on Follow Up
  • Anthem Sues Express Scripts for $3B
  • FDA Wants Clinical Data To Make Biosimilars Substitutable?
  • Maximum Allowable Cost MAC™

 

Issue # 279 | May 19th, 2016

  • Commentary:Prior Authorizations for MedicationsUnder the Medical Benefit
  • Pro Pharma Announces New Medical Specialty Analytical Report™

 

Issue # 278 | May 5th, 2016

  • Use of Proton Pump Inhibitors Linked to Increased Dementia Risk?
  • Why is the Risk of Dementia Decreasing?
  • Interferon-Free Therapy for Hepatitis C?
  • Pro Pharma Introduces Information Exchange Hub: RxInfoX™

 

Issue # 277 | April 21st, 2016

  • Factor Xa Inhibitor Antidote?
  • Narcan Nasal Spray
  • FDA Approves New Gout Medication
  • Comprehensive Specialty Analyses™

 

Issue # 276 | April 7th, 2016

  • Naloxone For Opiate Overdose
  • Invoice Screens™

 

Issue # 275 | March 24th, 2016

  • Commentary: When Opiates Create Pain
  • Mapping Disease Outbreaks
  • Commentary: Fraud, Waste and Abuse (FWA) Prevention
  • Clinical Compliance™

 

Issue # 274 | March 10th, 2016

  • FDA Drug Review Processes Are Changing to Meet the Influx of New Generics from National & International Manufacturers
  • Look for Seven $1 Billion-Plus Drugs Reaching the Market in 2016
  • Community Pharmacies are Counting on Federal Legislation to Force PBMs to Reimburse at Cost or Cost +
  • Benefit Management & Oversight™

 

Issue # 273 | February 23rd, 2016

  • Pharmacists Want Supreme Court to Hear Religious Objections Case
  • The Law of Large Numbers and The Affordable Care Act (ACA) - Commentary
  • New Report Calls for Increased Focus on Diagnostic Errors
  • Trend Management™

 

Issue # 272 | February 11th, 2016

  • Financiers Buying Urgent Care Centers
  • Seattle Pharmacy Makes House Calls
  • New Jersey Permits Pharmacy-Level Substitution of Biosimilars
  • Operational Strategy and Strategic Implementation™

 

Issue # 271 | January 26th, 2016

  • Sandoz Biosimilar Takes Aim at Amgen's Pegfilgrastim
  • Brand-Name Dugs Increase Cost but Not Patient Satisfaction
  • Medicaid Denial for HCV Drugs Nearing 50% In Some States
  • Data Analytics™

 

Issue # 270 | January 14th, 2016

  • Response to Precision Medicine
  • Mid-Levels Providing Chronic Care Management (CCM)
  • Quality Is Not Illusory
  • Who is ProData Analytics™?

 

2015

Issue # 269 | December 17th, 2015

  • Pioneer ACO Models Versus Home Grown Models
  • Are Doctors Mrore Price-Conscious When Prices Are Displayed When They Prescribe?
  • AMA Recommends Synchronized Prescription Renewals
  • Pro Pharma Launches Newly Redesigned Mobile and Use Friendly Website

 

Issue # 268 | November 12th, 2015

  • The Movement Towards Value-Based Care
  • Sizzurp - The Cough Drink of Choice
  • Drug Transparency Laws and Possible Outcomes
  • To Our Veterans and Troops

 

Issue # 267 | October 29th, 2015

  • Stop Hormone Therapy After a Heart Attack?
  • California Laying Down the Law on Vaccinations
  • Hepatitis C: Still Untreatable to Some
  • Halloween is fast approaching...Are you scared of increasing Drug Spend yet?

 

Issue # 266 | October 15th, 2015

  • Wide Variance in the Cost of Procedures
  • A Communication Problem – Nurses vs. Doctors?
  • Heart Disease Linked to Psoriasis
  • Pro Pharma JCode Calculator™

 

Issue # 265 | October 1st, 2015

  • Population Health vs. Precision Medicine
  • Evaluating Another FDA Approval: Repatha
  • Omega-3 and Cognitive Health - The Fishy Reality
  • Pro Pharma JCode Calculator™

 

Issue # 264 | September 3rd, 2015

  • Is Precision Medicine Linked to a Perfect DNA Model?
  • New Treatments for Cholesterol –Expense Is The Only Discussion
  • Nationwide E-prescribing of Controlled Substances
  • Pro Pharma's Invoice Screening™

 

Issue # 263 | September 3rd, 2015

  • FDA Targets Severe Joint Pain Due to Specific Class of Diabetes Drugs
  • Is Psoriasis linked to Abnormal Heart Rhythms?
  • Distance from Oncology Providers Can Affect Treatment
  • Pro Pharma's Comprehensive Specialty Analysis™

 

Issue # 262 | August 19th, 2015

  • State MAC Lists Available to Everyone!
  • What Are Information Technology(IT) Priorities for Hospitals?
  • Waht is the Best Strategy for Lowering Blood Pressure for Patients with Diabetes or Kidney Disease?
  • Pro Pharma's JCode Calculator™

 

Issue # 261 | August 6th, 2015

  • Another Antipsychotic Medication: Rexulti
  • The Difficulties of Being a Player in the Retail Pharmacy Game
  • A Tough Pill to Swallow: Hepatitis C
  • Pro Pharma's JCode Calculator™

 

Issue # 260 | July 23rd, 2015

  • $1 Million per-Patient-per-Year for Cancer Immunotherapy?
  • Cancer Survival Is Now 2/3 by 5 Years
  • Is Hoarding Data a Target for Hacking?
  • Pro Data Analytics™

 

Issue # 259 | July 9th, 2015

  • Drug Pricining for Ondansetron: Implications
  • Benadryl: The Evil Culprit
  • Impact of the Affordable Care Act
  • Comprehensive Specialty Analyses™

 

Issue # 258 | June 25th, 2015

  • “Claim Denied…”
  • Patient-Physician Treatment Contract Forms
  • Too Much Testosterone Raises Safety Concerns
  • Pro Pharma Cloud™

 

Issue # 257 | June 11th, 2015

  • It’s All about Perspective
  • Providers Cannot Sue States Over Medicaid Reimbursement
  • A Follow Up – To Give or Not to Give: Bisphosphonates
  • Pro Pharma's Custom RxMAC™

 

Issue # 256 | May 28th, 2015

  • Specialty – Coding Units Or How Much Did The Patient Receive?
  • Health Goes High Tech – At Least The Apps Do
  • Increases In Medical Cost Are Driven By More Than Price
  • Quality Management Program ™

 

Issue # 255 | May 14th, 2015

  • “The Doc Fix”
  • LOW-T in HIV
  • Transparent Electronic Health Record
  • Comprehensive Specialty Analyses ™

 

Issue # 254 | April 30th, 2015

  • Step Aside! OptumRx and Catamaran are Merging
  • I Can’t Remember
  • Lower Pain and Lower Sugar?
  • Pro Pharma Announces Their Spring Educational Series

 

Issue # 253 | April 16th, 2015

  • Drug Price Increases Since 2007 – Outrageous?
  • Why is Everyone Vitamin D Deficient?
  • Is My Flu Shot Working?
  • Pro Pharma Announces Their Spring Educational Series

 

Issue # 252 | April 2nd, 2015

  • Ouch! New Pain Guidelines
  • FYI: Correct Coding for Supportive Therapy
  • How France Fights Back Sovaldi Prices
  • Comprehensive Specialty Analyses™

 

Issue # 251 | March 19th, 2015

  • National Comprehensive Cancer Network (NCCN) Guidelines Online
  • Aspirin, the New Vitamin?
  • I’m So Itchy!
  • Treatment Calendar™

 

Issue # 250 | March 5th, 2015

  • The Happiest Drugs On Earth!
  • Concerta Generics No Longer Equivalent?
  • Chronotherapy... Placing Circadian Rhythm onto Drugs
  • Comprehensive Specialty Analyses™

 

Issue # 249 | February 19th, 2015

  • Purple is the New Orange
  • Stages of Chronic Kidney Disease
  • Are We Really Changing Hypertension Treatment?
  • Quality Management Program™

 

Issue # 248 | February 5th, 2015

  • Specialty Phone Applications
  • Concerns of Combination Use of Benzodiazepines and Opioids
  • Validity of Screening Tools: PHQ-9 and MMSE
  • Pro Pharma Invoice Screening™

 

Issue # 247 | January 22nd, 2015

  • Specialty Benchmark Data
  • The Rhythm of Your Heart
  • Can you really take Acetaminophen with Isoniazid?
  • Pro Pharma JCode Calculator™

 

Issue # 246 | January 8th, 2015

  • Specialty Spotlight
  • The Rhythm of Your Heart
  • Can you really take Acetaminophen with Isoniazid?
  • Pro Pharma JCode Calculator ™